| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.002 | 1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |